PositiveID seeks patent for iGlucose system

DELRAY BEACH, Fla. PositiveID has filed nonprovisional patent application for its iGlucose system with the U.S. Patent and Trademark Office.

The iGlucose system uses wireless SMS messaging to automatically communicate a diabetic patient’s blood glucose levels from any data-capable glucose meter to an online database. PositiveID said the system is designed to automatically communicate with a wide variety of glucometers by utilizing electronics and stored information that will query and recognize a particular glucometer when connected to the device. The program

Scott R. Silverman, chairman and CEO of PositiveID, said, “We are pleased to file this patent application to protect the key technology underlying the iGlucose System. We believe iGlucose has the potential to revolutionize the way diabetics and their healthcare providers manage this widespread disease through more effective and consistent communication of blood sugar levels.”